{
  "nct_id": "NCT32913640",
  "indication": "Hypertension",
  "phase": "Phase 3",
  "sample_size": 499,
  "duration_weeks": 42,
  "dropout_rate": 0.2,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "SBP reduction"
  ],
  "secondary_endpoints": [
    "24-hour ambulatory BP reduction",
    "DBP reduction"
  ],
  "outcome_summary": "Did not meet primary efficacy endpoints",
  "success": 0,
  "failure_reason": "Pharmacokinetic issues with drug exposure",
  "start_date": "2022-11-12",
  "completion_date": "2023-09-02"
}